🇺🇸 FDA

Intelligence Platform

Patents

Browse 27 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12233087

Palladium hyaluronic acid particles and methods of managing cancer or angiogenic condition

The United States Government represented byt The United States Department of Veterans Affairs · Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12162818

Inhibitors of the n-terminal domain of the androgen receptor

The United States Government represented by the Department of Veterans Affairs · Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12144788

Visual cycle modulators

The United States Government as Represented by The Department of Veteran Affairs · Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12049486

PAC1 receptor agonists (MAXCAPs) and uses thereof

The United States Government represented by the Department of Veterans Affairs · Granted Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11951152

Microparticle compositions for controlled delivery of telmisartan and actinomycin D

The United States Government as Represented by The Department of Veteran Affairs · Granted Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11806389

Compositions and methods for treating central nervous system injury

The United States Government as Represented by The Department of Veteran Affairs · Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11752220

Method of delivering genes and drugs to a posterior segment of an eye

The United States Government as Represented by the Department of Veterans Affair · Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11730799

Cancer vaccines and methods of producing and using same

THE UNITED STATES GOVERNMENT DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11680079

Nucleic acid aptamers to treat histone-induced disease states

The United States Government as Represented by The Department of Veteran Affairs · Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11643656

Antisense therapies for treating cancer

The United States Government represented by the Department of Veterans Affairs · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11278521

GAS5 binding compounds, formulations, and uses thereof

THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS OFFICE OF GENERAL COUNSEL—PSG IV (024) · Granted Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11274303

Olmalinc as a diagnostic and therapeutic target for NAFLD, NASH, metabolic syndrome, and h

The United States Government represented by the Department of Veterans Affairs · Granted Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11253489

Visual cycle modulators

The United States Government as Represented by The Department of Veteran Affairs · Granted Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11236139

Combination immunotherapy

The United States Government represented by the Department of Veterans Affairs · Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11186622

PAC1 receptor agonists (MAXCAPS) and uses thereof

The United States Government represented by the Department of Veterans Affairs · Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11129808

PKC-delta-I inhibitor formulations and uses thereof

THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERRANS AFFAIRS OFFICE OF THE GENERAL COUNSEL · Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11083801

Factor VIII mutation repair and tolerance induction

The United States Government Represented by the Departrment of Veteran Affairs · Granted Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11053290

Modified Tamm-Horsfall protein and related compositions and methods of use

The United States Government as Represented by the Department of Veterans Affair · Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10961301

Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

The United States Government represented by the Department of Veterans Affairs · Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10688063

Treating and/or preventing insulin-resistance related weight gain

The United States Government as Represented by the Department of Veterans Affairs of General Counsel- PSG IV (024) · Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10614684

Treatment of kidney diseases associated with elevated AVP

THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE · Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10583148

Methods and devices for bone infection treatment selection

The United States Government · Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10441642

Immunogenic compositions and vaccines for preventing or treating filarial disease

The United States Government, as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10376495

Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor

The United States Government as Represented by the Department of Veterans · Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted